SEC Filing Details
Document Details
Form
Filing Date
Dec 20, 2022
Document Date
Dec 16, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Arrowhead Pharmaceuticals Inc.
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
Filer
Anzalone Christopher Richard